Allarity Therapeutics Inc (NASDAQ:ALLR)’s traded shares stood at 1.59 million during the last session, with the company’s beta value hitting 0.27. At the close of trading, the stock’s price was $0.78, to imply an increase of 10.17% or $0.08 in intraday trading. The ALLR share’s 52-week high remains $264.00, putting it -33746.15% down since that peak but still an impressive 12.82% since price per share fell to its 52-week low of $0.68.
Analysts have given a consensus recommendation of Buy for Allarity Therapeutics Inc (ALLR), translating to a mean rating of 1.00. Of 1 analyst(s) looking at the stock, 0 analyst(s) give ALLR a Sell rating. 0 of those analysts rate the stock as Overweight while 0 advise Hold as 1 recommend it as a Buy. 0 analyst(s) have given it an Underweight rating. Estimates put the company’s current-quarter earnings per share at 0.
Allarity Therapeutics Inc (NASDAQ:ALLR) trade information
After registering a 10.17% upside in the last session, Allarity Therapeutics Inc (ALLR) has traded red over the past five days. The 5-day price performance for the stock is -16.90%, and -49.56% over 30 days. With these gigs, the year-to-date price performance is -33.62%.
ALLR Dividends
Allarity Therapeutics Inc has its next earnings report out in March. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too.
